Affimed N.V. (AFMD)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Adolf Hoess
Employees:
200
IM NEUENHEIMER FELD 582, 69120, HEIDELBERG, GERMANY 000000
49-6221-65307

Affimed N.V. focuses on discovering and developing cancer immunotherapies. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma. The company is also developing AFM24, a tetravalent, bispecific epidermal growth factor receptor, and CD16A-binding innate cell engager, which is in Phase IIa clinical trial for the treatment of advanced cancers.

Data derived from most recent annual or quarterly report
Market Cap 86.641 Million Shares Outstanding123.42 Million Avg 30-day Volume 840.08 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS
Price to Revenue11.5022 Debt to Equity0.1325 EBITDA-63.592 Million
Price to Book Value3.526 Operating Margin-153.6376 Enterprise Value339.25 Million
Current Ratio3.198 EPS Growth0 Quick Ratio3.136
1 Yr BETA 1.4366 52-week High/Low 5.1 / 0.68 Profit Margin-138.0243
Operating Cash Flow Growth-313.5328 Altman Z-Score1.2498 Free Cash Flow to Firm -91.769 Million
Earnings Report2023-03-30
View SEC Filings from AFMD instead.

Affimed N.V. YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding AFMD (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AFMD

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
AFFIMED NV AFMD 2023-03-24 16:15:03 UTC 4.1369 0.6831 1500000
AFFIMED NV AFMD 2023-03-24 15:45:03 UTC 4.1369 0.6831 2600000
AFFIMED NV AFMD 2023-03-24 15:15:03 UTC 4.1369 0.6831 2600000
AFFIMED NV AFMD 2023-03-24 14:45:03 UTC 4.1369 0.6831 2600000
AFFIMED NV AFMD 2023-03-24 14:15:03 UTC 4.1369 0.6831 2600000
AFFIMED NV AFMD 2023-03-24 13:45:03 UTC 3.9098 0.6602 2600000
AFFIMED NV AFMD 2023-03-24 13:15:04 UTC 3.9098 0.6602 2600000
AFFIMED NV AFMD 2023-03-24 12:45:03 UTC 3.9098 0.6602 2600000
AFFIMED NV AFMD 2023-03-23 22:15:04 UTC 3.9098 0.6602 2500000
AFFIMED NV AFMD 2023-03-23 21:45:04 UTC 3.9108 0.6592 2500000
AFFIMED NV AFMD 2023-03-23 21:15:04 UTC 3.9108 0.6592 2500000
AFFIMED NV AFMD 2023-03-23 20:45:03 UTC 3.8419 0.7281 2500000
AFFIMED NV AFMD 2023-03-23 20:15:03 UTC 3.8419 0.7281 2500000
AFFIMED NV AFMD 2023-03-23 19:45:03 UTC 3.8419 0.7281 2500000
AFFIMED NV AFMD 2023-03-23 19:15:03 UTC 3.8419 0.7281 2500000
AFFIMED NV AFMD 2023-03-23 18:45:04 UTC 3.8419 0.7281 2500000
AFFIMED NV AFMD 2023-03-23 18:15:03 UTC 3.8419 0.7281 2500000
AFFIMED NV AFMD 2023-03-23 17:45:03 UTC 3.8419 0.7281 2500000
AFFIMED NV AFMD 2023-03-23 17:15:03 UTC 3.8419 0.7281 2500000
AFFIMED NV AFMD 2023-03-23 16:45:04 UTC 3.8434 0.7266 2500000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

Elevate your investments